Sana Biotechnology Inc SANA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:02 AM EST
24.48UNCH (UNCH)
Volume
226
Close
24.48quote price arrow down-5.38 (-18.02%)
Volume
672,403
52 week range
24.41 - 44.60

...

Loading . . .

KEY STATS

  • Open30.21
  • Day High30.69
  • Day Low24.41
  • Prev Close24.48
  • 52 Week High44.60
  • 52 Week High Date02/10/21
  • 52 Week Low24.41
  • 52 Week Low Date03/03/21
  • Market Cap4.586B
  • Shares Out187.34M
  • 10 Day Average Volume0.43M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.22
  • P/E (TTM)-111.07
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-211.623M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Sana Biotechnology Inc News

There is no recent news for this security.

Latest SANA News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Sana Biotechnology, Inc is a preclinical-stage biotechnology company. The Company is focused on creating and delivering engineered cells as medicines for patients. The Company develops in vivo and ex vivo cell engineering platforms for treatment across an array of therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system (CNS) disorders, cardiovascular diseases, and genetic disorders, among others. The Company’s process of repairing...
Hans Bishop
Chairman
Steven Harr M.D.
President
Nate Hardy
Chief Financial Officer
Address
188 East Blaine Street
Suit 400, Suite 400
Seattle, WA
98102
United States